Hinge Health (NYSE:HNGE) released a five year claims analysis on its digital musculoskeletal program, reporting sustained reductions in surgeries and healthcare spending for employers and health plans ...

Detailed price information for Omada Health Inc (OMDA-Q) from The Globe and Mail including charting and trades.

A growing wave of clinical trials is testing whether principles from behavioral economics can improve adherence to weight management strategies, one of the most persistent challenges in obesity care.

Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Goldman Sachs 47th Annual Global Healthcare ...

Detailed price information for Omada Health Inc (OMDA-Q) from The Globe and Mail including charting and trades.

Omada Health Inc. stock grades by Barron's. View OMDA fundamental and sentiment analysis powered by MarketGrader.

I initiate coverage on Omada Health with a Hold rating. The current price of ~$16 offers a not attractive enough risk-reward despite the underlying business quality. Omada is a fundamentally good ...

Eli Lilly is just wrapping up trials of its retatrutide, but consumers already are flocking to black-market versions. Can Lilly compete with copies of its own drug?

Omada joined Optum Rx’s Weight Engage portfolio to help employers expand responsible, clinically supported access to GLP‑1 and other anti‑obesity medications through their existing pharmacy benefit ...

SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company’s Employer Connect program. Omada ...

Revenue up 42% Year over Year; Total Members Surpass One Million; Expanded Channels Now Include All Three of the Nation’s Leading PBMs SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health, Inc ...